Search results for " Pharmaceutical"

showing 10 items of 409 documents

Comparative Study of Different Methods for the Prediction of Drug–Polymer Solubility

2015

In this study, a comparison of different methods to predict drug-polymer solubility was carried out on binary systems consisting of five model drugs (paracetamol, chloramphenicol, celecoxib, indomethacin, and felodipine) and polyvinylpyrrolidone/vinyl acetate copolymers (PVP/VA) of different monomer weight ratios. The drug-polymer solubility at 25 °C was predicted using the Flory-Huggins model, from data obtained at elevated temperature using thermal analysis methods based on the recrystallization of a supersaturated amorphous solid dispersion and two variations of the melting point depression method. These predictions were compared with the solubility in the low molecular weight liquid ana…

Vinyl CompoundsRecrystallization (geology)PolymersChemistry PharmaceuticalIndomethacinAnalytical chemistryPharmaceutical ScienceFlory–Huggins solution theorychemistry.chemical_compoundDrug StabilityDrug DiscoveryVinyl acetatemedicineSolubilityThermal analysisAcetaminophenSupersaturationChromatographyCalorimetry Differential ScanningFelodipinePolyvinylpyrrolidonePovidonePyrrolidinonesChloramphenicolSolubilitychemistryCelecoxibThermodynamicsMolecular MedicineCrystallizationMelting-point depressionmedicine.drugMolecular Pharmaceutics
researchProduct

A Promising New Method to Estimate Drug-Polymer Solubility at Room Temperature

2016

The established methods to predict drug-polymer solubility at room temperature either rely on extrapolation over a long temperature range or are limited by the availability of a liquid analogue of the polymer. To overcome these issues, this work investigated a new methodology where the drug-polymer solubility is estimated from the solubility of the drug in a solution of the polymer at room temperature using the shake-flask method. Thus, the new polymer in solution method does not rely on temperature extrapolations and only requires the polymer and a solvent, in which the polymer is soluble, that does not affect the molecular structure of the drug and polymer relative to that in the solid st…

Work (thermodynamics)Materials sciencePolymersChemistry PharmaceuticalPharmaceutical Science02 engineering and technologyFlory–Huggins solution theory030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineDrug StabilityTransition TemperatureOrganic chemistrySolubilityThermal analysisChromatography High Pressure LiquidAcetaminophenchemistry.chemical_classificationPolymerAtmospheric temperature range021001 nanoscience & nanotechnologySolutionsSolventHildebrand solubility parameterChloramphenicolPharmaceutical PreparationsSolubilityChemical engineeringchemistryCelecoxib0210 nano-technologyJournal of Pharmaceutical Sciences
researchProduct

Hydration and dehydration kinetics of xylazine hydrochloride

2009

From the experiments where mixture of xylazine hydrochloride hydrate H and anhydrous X were held at constant conditions, the stable form of xylazine hydrochloride can be found out. To determine equilibrium relative humidity, the unstable form of xylazine hydrochloride was inserted in thermostated humidity chamber and its weight was recorded by weighing the sample outside the chamber. The kinetic model and the rate constant for each condition were determined. The rate constants give information regarding the speed of the process at every experimentally used relative humidity. Thus using the data in coordinates k – p for each temperature it is possible to determine the water vapor pressure of…

XylazineStereochemistryChemistry PharmaceuticalVapour pressure of waterEnthalpyAnalytical chemistryPharmaceutical ScienceXylazineReaction rate constantDrug StabilitymedicineRelative humidityDesiccationChemistryTemperaturefood and beveragesHumidityHumidityGeneral MedicinehumanitiesKineticsAnhydrousThermodynamicsCrystallizationHydrateAdrenergic alpha-Agonistsmedicine.drugPharmaceutical Development and Technology
researchProduct

Catalysis Concepts in Medicinal Inorganic Chemistry

2018

Catalysis has strongly emerged in the field of medicinal inorganic chemistry as a suitable tool to deliver new drug candidates and to overcome drawbacks associated to metallodrugs. In this Concept article, we discuss representative examples of how catalysis has been applied in combination with metal complexes to deliver new therapy approaches. In particular, we explain key achievements in the design of catalytic metallodrugs that damage biomolecular targets and in the development of metal catalysis schemes for the activation of exogenous organic prodrugs. Moreover, we discuss our recent discoveries on the flavin-mediated bioorthogonal catalytic activation of metal-based prodrugs; a new cata…

antiproliferationChemistry PharmaceuticalInorganic chemistryAntineoplastic Agents010402 general chemistry01 natural sciencesCatalysisCatalysisCatalysibioinorganic chemistryAntineoplastic AgentCoordination ComplexesInorganic ChemicalHumansProdrugsmetallodrugInorganic ChemicalphotochemistryCoordination Complexe010405 organic chemistryChemistryOrganic ChemistryGeneral Chemistry0104 chemical sciencesInorganic ChemicalsSettore CHIM/03 - Chimica Generale E InorganicaBioorthogonal chemistryprodrugHuman
researchProduct

Effects of n-3 Polyunsaturated Fatty Acids (ω-3) Supplementation on Some Cardiovascular Risk Factors with a Ketogenic Mediterranean Diet

2015

Background: the ketogenic diet (KD) has become a widely used nutritional approach for weight loss. Some of the KD’s positive effects on metabolism and cardiovascular risk factors are similar to those seen after n-3 polyunsaturated fatty acids (ω-3) supplementation. We hypothesized that a ketogenic Mediterranean diet with phytoextracts combined with ω-3 supplementation may have increased positive effects on cardiovascular risk factors and inflammation. Methods: We analyzed 34 male overweight subjects

cardiovascular risk factorsBlood GlucoseMaleMediterranean dietinflammatory cytokinesmedicine.medical_treatmentN-3 polyunsaturated fatty acidPharmaceutical ScienceOverweightDiet Mediterraneanchemistry.chemical_compoundRisk FactorsWeight lossDrug DiscoveryInsulinlcsh:QH301-705.5Pharmacology Toxicology and Pharmaceutics (miscellaneous)Adipositychemistry.chemical_classificationCardiovascular risk factors; Inflammatory cytokines; Ketogenic diet; N-3 polyunsaturated fatty acids; Omega-3; Weight loss; Drug Discovery3003 Pharmaceutical ScienceMiddle Agedn-3 polyunsaturated fatty acidsketogenic dietCardiovascular DiseasesCytokinesomega-3medicine.symptomDiet KetogenicPolyunsaturated fatty acidAdultmedicine.medical_specialtyInflammatory cytokineBiologyCardiovascular risk factorWeight loArticleInternal medicineFatty Acids Omega-3Weight LossmedicineHumansTriglyceridesAgedAdiponectinPlant ExtractsCholesterolDrug Discovery3003 Pharmaceutical Science<i>n</i>-3 polyunsaturated fatty acidsCholesterol LDLOverweightEndocrinologylcsh:Biology (General)chemistryDietary SupplementsUric acidKetogenic dietMarine Drugs
researchProduct

Synthesis of substituted carbamo(dithioperoxo)thioates as potential BCA2-inhibitory anticancer agents

2015

A new, simple, one-step synthetic route to carbamo(dithioperoxo)thioates from commercially available starting materials is described. The key step of this new synthetic approach involves the tetrabromomethane-promoted reaction between secondary amines, carbon disulfide and alkyl thiols under basic conditions at room temperature. New compounds from this series selected for anticancer screening showed selective sub-micromolar activity within BCA2-expressing human breast cancer cell lines.

chemistry.chemical_classificationCarbamo(dithioperoxo)thioateRMCarbon disulfideStereochemistryTetrabromomethaneDrug Discovery3003 Pharmaceutical ScienceOrganic ChemistryTetrabromomethaneCombinatorial chemistryBiochemistrychemistry.chemical_compoundchemistryAnticancer agentDrug DiscoveryBCA2 inhibitorCancer cell linesHuman breastAlkylDisulfiram analogue
researchProduct

Computational Study of Nanosized Drug Delivery from Cyclodextrins, Crown Ethers and Hyaluronan in Pharmaceutical Formulations

2015

Abstract The problem in this work is the computational characterization of cyclodextrins, crown ethers and hyaluronan (HA) as hosts of inclusion complexes for nanosized drug delivery vehicles in pharmaceutical formulations. The difficulty is addressed through a computational study of some thermodynamic, geometric and topological properties of the hosts. The calculated properties of oligosaccharides of D-glucopyranoses allow these to act as co-solvents of polyanions in water. In crown ethers, the central channel is computed. Mucoadhesive polymer HA in formulations releases drugs in mucosas. Geometric, topological and fractal analyses are carried out with code TOPO. Reference calculations are…

chemistry.chemical_classificationCyclodextrinsMolecular StructureStereochemistryChemistry PharmaceuticalGeneral MedicinePolymerFractal dimensionRelative stabilityNanostructuresMucoadhesive polymersDrug Delivery SystemsFractalchemistryCrown EthersDrug DiscoveryDrug deliveryPhysical chemistryReactivity (chemistry)Hyaluronic AcidParticle SizeHydrate
researchProduct

Tailor‐Made Amino Acids and Fluorinated Motifs as Prominent Traits in Modern Pharmaceuticals

2020

Structural analysis of modern pharmaceutical practices allows for the identification of two rapidly growing trends: the introduction of tailor-made amino acids and the exploitation of fluorinated motifs. Curiously, the former represents one of the most ubiquitous classes of naturally occurring compounds, whereas the latter is the most xenobiotic and comprised virtually entirely of man-made derivatives. Herein, 39 selected compounds, featuring both of these traits in the same molecule, are profiled. The total synthesis, source of the corresponding amino acids and fluorinated residues, and medicinal chemistry aspects and biological properties of the molecules are discussed.

chemistry.chemical_classificationHydrocarbons Fluorinated010405 organic chemistryDrug discoveryChemistry PharmaceuticalOrganic ChemistryTotal synthesisGeneral Chemistry010402 general chemistry01 natural sciencesCatalysis0104 chemical sciencesAmino acidchemistry.chemical_compoundPharmaceutical PreparationsBiochemistrychemistryBiological propertyHumansMoleculeIdentification (biology)Amino AcidsXenobioticChemistry – A European Journal
researchProduct

The Quest for Mononuclear Gold(II) and Its Potential Role in Photocatalysis and Drug Action.

2017

The chemistry of gold strongly focuses on the ubiquitous oxidation states +I and +III. The intermediate oxidation state +II is generally avoided in mononuclear gold species. In recent years, gold(II) has been increasingly suggested as a key intermediate in artificial photosynthesis systems, with gold(III) moieties acting as electron acceptors, as well as in gold-catalyzed photoredox catalysis and radical chemistry. This Minireview provides a concise summary of confirmed and characterized mononuclear open-shell gold(II) complexes. Recent findings on structural motifs and reactivity patterns will be discussed. Exciting developments in the fields of photosynthesis, photocatalysis, and potentia…

chemistry.chemical_classificationMolecular Structure010405 organic chemistryChemistryRadicalChemistry PharmaceuticalPhotoredox catalysisElectronsGeneral ChemistryElectron acceptor010402 general chemistryPhotochemical Processes01 natural sciencesCombinatorial chemistryCatalysis0104 chemical sciencesArtificial photosynthesisElectron transferOxidation statePhotocatalysisOrganic chemistryReactivity (chemistry)Organogold CompoundsAngewandte Chemie (International ed. in English)
researchProduct

Lonoctocog alfa (rVIII-SingleChain) for the treatment of haemophilia A

2017

Introduction: The administration of factor VIII (FVIII) concentrates on-demand or on long-term prophylaxis is the effective and safe standard of care of patients with hemophilia A (HA). Development of neutralizing antibodies against exogenous FVIII and the short half-life of the current available products remain major challenges. There is currently a great interest towards newer FVIII products with the goal of reducing the inhibitor risk and increasing the half-life. Area covered: In this review, the authors describe the efficacy and safety of rVIII-SingleChain (Lonoctocog alfa), the first and only single chain recombinant FVIII (rFVIII) molecule developed for the prevention and treatment o…

congenital hereditary and neonatal diseases and abnormalitiesPediatricsmedicine.medical_specialtyHaemophiliaStandard of caresingle-chainHaemophilia AClinical BiochemistrySingle chain030204 cardiovascular system & hematologyHaemophiliaHemophilia A03 medical and health sciences0302 clinical medicineLONOCTOCOG ALFAhemic and lymphatic diseasesDrug DiscoverymedicineHumansPharmacologyClinical Trials as TopicFactor VIIIbusiness.industryCoagulantsDrug Discovery3003 Pharmaceutical ScienceRecombinant Proteinmedicine.diseaseRecombinant ProteinsCoagulantbusiness030215 immunologyHalf-LifeHuman
researchProduct